Development of recombinant vaccines against infectious bursal disease

Biotechnology Annual Review

Volumn 3, Issue C, 1997, Pages 151-168

  Vakharia, Vikram N ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

active and passive protection; baculovirus expression; birnavirus; Gumboro disease; infectious bursal disease virus (IBDV); live virus vectored vaccine; recombinant fowlpox virus; recombinant herpesvirus of turkeys (HVT); recombinant IBDV (rIBDV); recombinant vaccine; reverse genetics; virus like particles; yeast expression

Indexed keywords

EID: 0001466395     PISSN: 13872656     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1387-2656(08)70032-2     Document Type: Article

References (73)

1. Cosgrove A.S. An apparently new disease of chickens-avian nephrosis. Avian Dis 6 (1962) 385-389
2. Dobos P., Hill B.J., Hallet R., Kells D.T.C., Becht H., and Teninges D. Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded genomes. J Virol 32 (1979) 593-605
3. Cheville N.F. Studies on the pathogenesis of Gumboro disease in the bursa of Fabricius, spleen and thymus of the chicken. Am J Pathol 51 (1967) 527-551
4. Lukert P.D., and Hitchner S.B. In: Hofstad M.S., Barnes H.J., Calnek B.W., Reid W.M., and Yoder H.W. (Eds). Diseases of Poultry. 8th edn (1984), Iowa State University Press, Ames 566-576
5. Hitchner S.B. Persistence of parental infectious bursal disease antibody and its effects on susceptibility of young chickens. Avian Dis 15 (1971) 894-900
6. Winterfield K.W., Fadly A.M., and Bickford A. Infectivity and distribution of infectious bursal disease virus in the chicken. Persistence of the virus and lesions. Avian Dis 16 (1972) 622-632
7. Allan W.H., Faragher J.T., and Cullen G.A. Immunosuppression by the infectious bursal agent in chickens immunized against Newcastle disease. Vet Rec 90 (1972) 511-512
8. Kibenge F.S.B., Dhillon A.S., and Russell R.G. Biochemistry and immunology of infectious bursal disease virus. J Gen Virol 69 (1988) 1757-1775
9. Benton W.J., Cover M.S., and Rosenberger J.K. Studies on the transmission of the infectious bursal agent (IBA) of chickens. Avian Dis 11 (1967) 430-438
10. Parkhurst R.T. On-the-farm studies of Gumboro disease in broilers. Avian Dis 8 (1964) 584-596
11. McFerran J.B., McNulty M.S., McKilhop E.R., Connor T.J., McCracken R.M., Collins D.S., and Allan G.N. Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys and ducks: demonstration of a second serotype. Avian Path 9 (1980) 395-404
12. Winterfield R.W., and Thacker H.L. Immune response and pathogenicity of different strains of infectious bursal disease virus applied as vaccines. Avian Dis 5 (1978) 253-260
13. Ismail N.M., Saif Y.M., and Moorhead P.D. Lack of pathogenicity of five serotype 2 infectious bursal disease viruses. Avian Dis 32 (1988) 757-759
14. Rosenberger JK, Cloud SS, Isolation and characterization of variant infectious bursal disease viruses. Proc. 123rd Ann. Meeting of the AVMA, 1986, Abstract 181.
15. Snyder D.B., Lana D.P., Savage P.K., Yancey F.S., Mengel S.A., and Marquardt W.W. Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates. Avian Dis. 32 (1988) 535-539
16. Snyder D.B., Vakharia V.N., and Savage P.K. Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease virus in the United States. Arch Virol 127 (1992) 89-101
17. Chettle N., Stuart J.C., and Wyeth P.J. Outbreak of virulent infectious bursal disease in East Anglia. Vet Rec 125 (1989) 271-272
18. Van den Berg T.P., Gonze M., and Meulemans G. Acute infectious bursal disease in poultry: isolation and characterization of a highly virulent strain. Avian Path 20 (1991) 133-143
19. Nunoya T., Otaki Y., Tajima M., Hiraga M., and Saito T. Occurrence of acute infectious bursal disease with high mortality in Japan and pathogenicity of field isolates in specific-pathogen-free chickens. Avian Dis 36 (1992) 597-609
20. Brown M.D., Green P., and Skinner M.A. VP2 sequences of recent European very virulent isolates of infectious bursal disease virus are closely related to each other but are distinct from those of classical strains. J Gen Virol. 75 (1994) 675-680
21. Dobos P. Peptide map comparison of the proteins of infectious bursal disease virus (IBDV). J Virol 32 (1979) 1046-1050
22. Müller H., and Becht H. Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles. J Virol. 44 (1982) 384-392
23. Azad A.A., Barrett S.A., and Fahey K.J. The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus. Virology 143 (1985) 35-44
24. Mundt E., and Müller H. Complete nucleotide sequences of 5′- and 3′-noncoding regions of both genome segments of different strains of infectious bursal disease virus. Virology 209 (1995) 10-18
25. Hudson P.J., McKern N.M., Power B.E., and Azad A.A. Genomic structure of the large RNA segment of infectious bursal disease virus. Nucl Acid Res 14 (1986) 5001-5012
26. Morgan M.M., Macreadie I.G., Harley V.R., Hudson P.J., and Azad A.A. Sequence of the small double-stranded RNA genomic segment of infectious bursal disease virus and its deduced 90-kDa product. Virology 163 (1988) 240-242
27. Mundt E., Beyer J., and Müller H. Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol 76 (1995) 437-443
28. Spies U., Müller H., and Becht H. Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products. Virus Res 8 (1987) 127-140
29. Spies U., and Müller H. Demonstration of enzyme activities required for the cap structure formation in infectious bursal disease virus, a member of the birnavirus group. J Gen Virol 17 (1990) 977-981
30. Becht H., Müller H., and Müller H.K. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J Gen Virol 69 (1988) 631-640
31. Fahey K.J., Erny K.M., and Crooks J. A conformational immunogen on VP2 of infectious bursal disease virus that passively protect chickens. J Gen Virol 70 (1989) 1473-1481
32. Azad A.A., Jagadish M.N., Brown M.A., and Hudson P.J. Deletion mapping in Escherichia coli of the large genomic segment of a birnavirus. Virology 161 (1987) 145-152
33. Jagadish M.N., Staton V.J., Hudson P.J., and Azad A.A. Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide. J Virol 62 (1988) 1084-1087
34. Jackwood D.J., and Saif Y.M. Antigenic diversity of infectious bursal disease viruses. Avian Dis 31 (1987) 766-770
35. Snyder D.B., Lana D.P., Cho B.R., and Marquardt W.W. Group and strain-specific neutralization sites of IBDV defined with monoclonal antibodies. Avian Dis 32 (1988) 527-534
36. Van der Marel P., Snyder D., and Liitticken D. Antigenic characterization of IBDV field isolates by their reactivity with a panel of monoclonal antibodies. Dtsch Tierarztl Wschr 97 (1990) 81-83
37. Bayliss C.D., Spies U., Shaw K., Peters R.W., Papageorgiou A., Müller H., and Boursnell M.E.G. A comparison of the sequences of segment A of four infectious bursal disease vims strains and identification of a variable region in VP2. J Gen Virol 71 (1990) 1303-1312
38. Brown M.D., and Skinner M.A. Coding sequences of both genome segments of a European 'very virulent' infectious bursal disease virus. Virus Res 40 (1996) 1-15
39. Vakharia V.N., He J., Ahamed B., and Snyder D.B. Molecular basis of antigenic variation in infectious bursal disease virus. Virus Res 31 (1994) 265-273
40. Kibenge F.S.B., Jackwood D.J., and Mercado C.C. Nucleotide sequence analysis of genome segment A of infectious bursal disease virus. J Gen Virol 71 (1990) 569-577
41. Lin Z., Kato A., Otaki Y., Nakamura T., Sasmaz E., and Ueda S. Sequence comparisons of a highly virulent bursal disease virus prevalent in Japan. Avian Dis 37 (1993) 315-323
42. Lana D.P., Beisel C.E., and Silva R.F. Genetic mechanisms of antigenic variation in infectious bursal disease virus: analysis of a naturally occurring variant virus. Virus Genes 6 (1992) 247-259
43. Heine H.G., Haritou M., Failla P., Fahey K., and Azad A. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. J Gen Virol. 22 (1991) 1835-1843
44. Vakharia V.N., Ahamed B., and He J. Use of polymerase chain reaction for efficient cloning of dsRNA segments of infectious bursal disease virus. Avian Dis 36 (1992) 736-742
45. Azad A.A., McKern N.M., Macreadie I.G., Failla P., Heine H.G., Chapman A., Ward C.W., and Fahey K.J. Physicochemical and immunological characterization of recombinant host-protective antigen (VP2) of infectious bursal disease virus. Vaccine 9 (1991) 715-722
46. Macreadie I.G., Vaughan P.R., Chapman A.J., McKern N.M., Jagadish M.N., Heine H.G., Ward C.W., Fahey K.J., and Azad A.A. Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast. Vaccine 8 (1990) 549-552
47. Vakharia V.N., Snyder D.B., He J., Edwards G.H., Savage P.K., and Mengel-Whereat S.A. Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens. J Gen Virol 74 (1993) 1201-1206
48. Vakharia V.N., Snyder D.B., Lütticken D., Mengel-Whereat S.A., Savage P.K., Edwards G.H., and Goodwin M.A. Active and passive protection against variant and classic infectious bursal disease virus induced by baculovirus expressed structural proteins. Vaccine 12 (1994) 452-456
49. Snyder D.B., Vakharia V.N., Mengel-Whereat S.A., Edwards G.H., Savage P.K., Lütticken D., and Goodwin M.A. Active cross-protection induced by a chimeric infectious bursal disease virus structural protein gene expressed by a baculovirus recombinant. Avian Dis 38 (1994) 701-707
50. Bayliss C.D., Peters R.W., Cook J.K.A., Reece R.L., Howes K., Binns M.M., and Boursnell M.E.G. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch Virol 120 (1991) 193-205
51. Heine H.G., and Boyle D.B. Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. Arch Virol 131 (1993) 277-292
52. Heine H.G., Hyatt A.D., and Boyle D.B. Modification of infectious bursal disease virus antigen VP2 for cell surface location fails to enhance immunogenicity. Virus Res 32 (1994) 313-328
53. Darteil R., Bublot M., Laplace E., Bouquet J.-F., Audonnet J.-C., and Riviere M. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology. 211 (1995) 481-490
54. Mundt E., and Vakharia V.N. Synthetic transcripts of double-stranded birnavirus genome are infectious. Proc Natl Acad Sci USA 93 (1996) 11131-11136
55. McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J., and Hilleman M.R. Human hepatitis B vaccine from recombinant yeast. Nature 307 (1984) 178-180
56. Summers M.D., and Smith G.E. A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Experiment Station Bulletin 1555 (1987)
57. O'Reilly D.R., Miller L.K., and Luckow V.A. Baculovirus expression vectors: a laboratory manual (1992), WH. Freeman and Co., New York
58. gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59 (1989) 103-112
59. Nonnenmacher B., Hubbert N., and Schiller J. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade 111 patients and controls from Columbia and Spain. J Infect Dis 172 (1995) 19
60. Urakawa T., Ferguson M., Minor P.D., Cooper J., Sullivan M., Almond J.W., and Bishop D.L. Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol 70 (1989) 1453-1463
61. Belyaev A.S., and Roy P. Development of baculovirus triple and quadruple expression vectors: coexpression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Nucl Acid Res. 21 (1993) 1219-1223
62. Bentley W.E., Wang M.Y., and Vakharia V. Development of an efficient bioprocess for poultry vaccines using high density insect cell culture. Ann NY Acad Sci 745 (1994) 336-356
63. Boyle D.B., and Coupar B.E.H. Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Res 10 (1988) 343-356
64. Boursnell M.E.G. Avipox vectors. In: Binns M.M., and Smith G.L. (Eds). Recombinant poxviruses (1992), CRC Press, Boca Raton 269-283
65. Ogawa R., Yanagida N., Saeki S., Saito S., Ohkawa S., Gotoh H., Kodama K., Kamogawa K., Sawaguchi K., and Iritani Y. Recombinant fowlpox viruses inducing protective immunity against Newcastle disease and fowlpox viruses. Vaccine 8 (1990) 486-490
66. Taylor J., Edbauer C., Rey-Senelonge A., Bouquet J.-F., Norton E., Goebel S., Desmettre P., and Paoletti E. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J Virol 64 (1990) 1441-1450
67. Nazerian K., Lee L.F., Yanagida N., and Ogawa R. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J Virol 66 (1992) 1409-1413
68. Morgan R.W., Gelb J., Schreurs C.S., Lütticken D., Rosenberger J.K., and Sondermeijer P.J. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis. 36 (1992) 858-870
69. Morgan R.W., Gelb J., Pope C.R., and Sondermeijer P.J. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: Onset of protection and effect of maternal antibodies. Avian Dis. 37 (1993) 1032-1040
70. Racaniello V.R., and Baltimore D. Cloned poliovirus cDNA is infectious in mammalian cells. Science 214 (1981) 916-919
71. Enami M., Luytjes W., Krystal M., and Palese P. Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci USA 87 (1990) 3802-3805
72. Schnell M.J., Mebatsion T., and Conzelmann K.K. Infectious rabies viruses from cloned cDNA. EMBOJ 13 (1994) 4195-4205
73. Robinson H.L., Hunt L.A., and Webster R.G. Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine 1993 (1993) 957-960